EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Eye-controlled endoscopy — a benchtop trial of a novel robotic steering platform — iGAZE2

Arun Sivananthan, Adrian Rubio-Solis, Ara Darzi, George Mylonas, Nisha Patel

Journal of Robotic Surgery · 2024

DOI: 10.1007/s11701-024-02022-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Robotic Surgery, 2024. Verfasst von Arun Sivananthan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Imperial College NHS Healthcare Trust, London, W2 1NY, UK. arun.sivananthan@nhs.net. Hauptthemen laut MEDLINE: Eye-Tracking Technology, Robotic Surgical Procedures. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The endoscopic control system has remained similar in design for many decades The remit of advanced therapeutic endoscopy continues to expand requiring precision control and high cognitive workloads. Robotic systems are emerging, but all still require bimanual control and expensive and large new systems. Eye tracking is an exciting area that can be used as an endoscope control system. This is a study to establish the feasibility of an eye-controlled endoscope and compare its performance and cognitive demand to use of a conventional endoscope. An eye gaze-control system consisting of eye-tracking glasses, customised software and a small motor unit was built and attached to a conventional endoscope. Twelve non-endoscopists used both the eye gaze system and a conventional endoscope to complete a benchtop task in a simulated oesophagus and stomach. Completion of tasks was timed. Subjective feedback was collected from each participant on task load using the NASA Task Load Index. Participants were significantly quicker completing the task using iGAZE2 vs a conventional endoscope (65.02 ± 16.34s vs 104.21 ± 51.31s, p = 0.013) Participants were also significantly quicker completing retroflexion using iGAZE2 vs a conventional endoscope (8.48 ± 3.08 vs 11.38 ± 5.36s, p = 0.036). Participants reported a significantly lower workload (raw NASA-TLX score) when using iGAZE2 vs the conventional endoscope (152.1 ± 63.4 vs 319.6 ± 81.6, p = 0.0001) (Fig. 7). Users found iGAZE2 to have a significantly lower temporal demand, mental demand, effort, mental demand, physical demand, and frustration level. The eye gaze system is an exciting, small, and retrofittable system to any endoscope. The system shows exciting potential as a novel endoscopic control system with a significantly lower workload and better performance in novices suggesting a more intuitive control system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Eye-Tracking TechnologyRobotic Surgical ProceduresHumansMaleEquipment DesignFemaleAdultTask Performance and AnalysisFeasibility StudiesEndoscopyEndoscopes

Stichwörter der Autor:innen

Eye trackingRobotic endoscopyTouchless interactions

Autor:innen und Institutionen

  • Imperial College NHS Healthcare Trust, London, W2 1NY, UK. arun.sivananthan@nhs.net.
  • The Hamlyn Centre for Robotic Surgery, Imperial College London, London, UK.
  • Imperial College NHS Healthcare Trust, London, W2 1NY, UK.

Zitieren

APA

Sivananthan, A., Rubio-Solis, A., Darzi, A., Mylonas, G., & Patel, N. (2024). Eye-controlled endoscopy — a benchtop trial of a novel robotic steering platform — iGAZE2. Journal of Robotic Surgery. https://doi.org/10.1007/s11701-024-02022-5

Vancouver

Sivananthan A, Rubio-Solis A, Darzi A, Mylonas G, Patel N. Eye-controlled endoscopy — a benchtop trial of a novel robotic steering platform — iGAZE2. Journal of Robotic Surgery. 2024. doi:10.1007/s11701-024-02022-5

BibTeX
@article{Sivananthan2024,
  author = {Sivananthan, Arun and Rubio-Solis, Adrian and Darzi, Ara and Mylonas, George and Patel, Nisha},
  title = {Eye-controlled endoscopy — a benchtop trial of a novel robotic steering platform — iGAZE2},
  journal = {Journal of Robotic Surgery},
  year = {2024},
  doi = {10.1007/s11701-024-02022-5}
}
Kostenlos starten →